A novel strategy for cancer immunotherapy based on the activation tumor-associated macrophages
- Prosjektnummer
- 2016111
- Ansvarlig person
- Alexandre Corthay
- Institusjon
- Oslo universitetssykehus HF
- Prosjektkategori
- Åpen prosjektstøtte
- Helsekategori
- Cancer, Inflammatory and Immune System, Respiratory
- Forskningsaktivitet
- 1. Underpinning, 5. Treatment Developement
NEI
Both Type I and Type II Interferons Can Activate Antitumor M1 Macrophages When Combined With TLR Stimulation.
Front Immunol 2018;9():2520. Epub 2018 nov 2
PMID: 30450098
Generation and Functional In Vitro Analysis of Semliki Forest Virus Vectors Encoding TNF-α and IFN-γ.
Front Immunol 2017;8():1667. Epub 2017 nov 30
PMID: 29276511
Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 Macrophages.
Front Immunol 2017;8():1383. Epub 2017 okt 26
PMID: 29123526
Immune Class Regulation and Its Medical Significance Part II of a Report of a Workshop on Foundational Concepts of Immune Regulation.
Scand J Immunol 2017 Apr;85(4):242-250.
PMID: 28236642
Immunological Tolerance. Part I of a Report of a Workshop on Foundational Concepts of Immune Regulation.
Scand J Immunol 2017 Feb;85(2):84-94.
PMID: 27885703
Rituximab efficiently depletes B cells in lung tumors and normal lung tissue.
F1000Res 2016;5():38. Epub 2016 jan 8
PMID: 27081474
Book Review: Rediscovering the Immune System as an Integrated Organ.
Scand J Immunol 2016 Jul;84(1):70-1.
PMID: 27099207
Immune Cell Composition in Human Non-small Cell Lung Cancer
Frontiers in Immunology, 2019
- Inger Øynebråten Prosjektdeltaker
- Baiba Olupe Prosjektdeltaker
- Branislava Stankovic Doktorgradsstipendiat (finansiert av denne bevilgning)
- Panagiotis Christopoulos Postdoktorstipendiat (finansiert av denne bevilgning)
- Alexandre Corthay Prosjektleder
- Astri Frafjord Prosjektdeltaker
- Baiba Kurena Forsker (annen finansiering)
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport